{"name":"AgonOx, Inc.","slug":"agonox-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"DP CD8 TIL KD","genericName":"DP CD8 TIL KD","slug":"dp-cd8-til-kd","indication":"Other","status":"phase_1"},{"name":"DP CD8 TIL","genericName":"DP CD8 TIL","slug":"dp-cd8-til","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"DP CD8 TIL KD","genericName":"DP CD8 TIL KD","slug":"dp-cd8-til-kd","phase":"phase_1","mechanism":"CD8+ tumor-infiltrating lymphocytes engineered or selected to recognize and attack cancer cells within the tumor microenvironment.","indications":[],"catalyst":""},{"name":"DP CD8 TIL","genericName":"DP CD8 TIL","slug":"dp-cd8-til","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE5TaXU0ZW1XV3V0aHVSQXZwWXozWHhRYjc3WjhnZnlUZ3BGQkdiQm1lNHc4MkV5RFZIU0tmclh4aGJFMmd2RER4SFY0YkROaXRQUTFlNVA2aXdYQ2ZIM0lZZTlRZ21xaDd5dHZWUlNfaW1EaHc?oc=5","date":"2024-04-09","type":"pipeline","source":"Built In","summary":"16 Biotech Companies in Portland to Know - Built In","headline":"16 Biotech Companies in Portland to Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE50UFBrZTNLWEFDY3RkcWVUNzE2Rk5LNGptR1d3Z1ZmNkttTTN0TFB4dXUtR191UFZYcG11ZzEzYkY1aEh6aElWeEFHMVNtS1VwV21HOWNuVW52Q1p0WGpIMHpUYm9ZZXk1ZW90ZGhwWktKUQ?oc=5","date":"2022-10-29","type":"pipeline","source":"Allied Market Research","summary":"Sarcoma Drugs Market Size & Share | Statistics Report - 2031 - Allied Market Research","headline":"Sarcoma Drugs Market Size & Share | Statistics Report - 2031","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPTlVXLVBiOW1FRU1KUk54SDJHbkNvanpxT1Q2dGZNN18xUV9RUzZWR3JsWkZkZnF2MlExZi1WaDVQU2JUMnFqVm1RSjB3NWlQeU15c2N5dWhpX2djbEEtbDBxaW5ucFlOdjN4cWUwVmE5NzROVXpoLTV6NU5HTjdzTmY5Qk9mdGw4Q1VEeU1qSVIyMDR4eHdULUo0cWFNVzdVN1Y0U1F1bG53N0pMLTZnYzJFSEFZWmJacEFLbUVjUlJlOC1YaHlKVHQ4RURpVUJ3U2V4bENhOFZCWGowbW1ONA?oc=5","date":"2019-09-24","type":"pipeline","source":"Proactive financial news","summary":"ImmunoPrecise subsidiary Talem enters into JV with biopharma company AgonOx - Proactive financial news","headline":"ImmunoPrecise subsidiary Talem enters into JV with biopharma company AgonOx","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}